{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:27:49Z","timestamp":1792985269792,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s13023-014-0199-0","type":"journal-article","created":{"date-parts":[[2014,12,18]],"date-time":"2014-12-18T09:13:35Z","timestamp":1418894015000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":109,"title":["An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A"],"prefix":"10.1186","volume":"9","author":[{"given":"Shahram","family":"Attarian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Vallat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Magy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Funalot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Marie","family":"Gonnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Lacour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"P\u00e9r\u00e9on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Dubourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Pouget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Micallef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Franques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-No\u00eblle","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karima","family":"Ghorab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Al-Moussawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Tiffreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerite","family":"Preudhomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armelle","family":"Magot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laur\u00e8ne","family":"Leclair-Visonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Stojkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lehert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Milet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolphe","family":"Hajj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamia","family":"Boudiaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Scart-Gr\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serguei","family":"Nabirotchkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickael","family":"Guedj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Chumakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,18]]},"reference":[{"key":"199_CR1","first-page":"65","volume":"42","author":"A Kocha\u0144ski","year":"2005","unstructured":"Kocha\u0144ski A: Molecular genetics studies in polish Charcot-Marie-Tooth families. \n                           Folia Neuropathol 2005, 42:65\u201373.","journal-title":"Folia Neuropathol"},{"key":"199_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11910-010-0158-7","volume":"11","author":"A Patzk\u00f3","year":"2011","unstructured":"Patzk\u00f3 A, Shy ME: Update on Charcot-Marie-Tooth disease. \n                           Curr Neurol Neurosci Rep 2011, 11:78\u201388.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"199_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1385\/NMM:8:1-2:3","volume":"8","author":"D Pareyson","year":"2006","unstructured":"Pareyson D, Scaioli V, Laur\u00e0 M: Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease. \n                           Neuromolecular Med 2006, 8:3\u201322.","journal-title":"Neuromolecular Med"},{"key":"199_CR4","volume-title":"\u115f","author":"TD Bird","year":"2014","unstructured":"Bird TD: Charcot-Marie-Tooth Neuropathy Type 1. In \u115f. ; 2014. GeneReviews\u00ae 1998 (Updated 2014) [http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1205\/]"},{"key":"199_CR5","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.nmd.2013.05.005","volume":"23","author":"B Gess","year":"2013","unstructured":"Gess B, Schirmacher A, Boentert M, Young P: Charcot-Marie-Tooth disease: frequency of genetic subtypes in a German neuromuscular center population. \n                           Neuromuscul Disord 2013, 23:647\u201351.","journal-title":"Neuromuscul Disord"},{"key":"199_CR6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1136\/jnnp-2011-300285","volume":"83","author":"C Foley","year":"2012","unstructured":"Foley C, Schofield I, Eglon G, Bailey G, Chinnery PF, Horvath R: Charcot-Marie-Tooth disease in Northern England. \n                           J Neurol Neurosurg Psychiatry 2012, 83:572\u20133.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"199_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0960-8966(91)90055-W","volume":"1","author":"P Raeymaekers","year":"1991","unstructured":"Raeymaekers P, Timmerman V, Nelis E, De Jonghe P, Hoogendijk JE, Baas F, Barker DF, Martin JJ, De Visser M, Bolhuis PA: Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a): the HMSN Collaborative Research Group. \n                           Neuromuscul Disord 1991, 1:93\u201397.","journal-title":"Neuromuscul Disord"},{"key":"199_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ng0492-29","volume":"1","author":"JR Lupski","year":"1992","unstructured":"Lupski JR, Wise CA, Kuwano A, Pentao L: Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A. \n                           Nat Genet 1992, 1:29\u201333.","journal-title":"Nat Genet"},{"key":"199_CR9","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nm1023","volume":"10","author":"E Passage","year":"2004","unstructured":"Passage E, Norreel JC, Noack-Fraissignes P, Sanguedolce V, Pizant J, Thirion X, Robaglia-Schlupp A, Pellissier JF, Font\u00e9s M: Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. \n                           Nat Med 2004, 10:396\u2013401.","journal-title":"Nat Med"},{"key":"199_CR10","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.nmd.2006.12.008","volume":"17","author":"F Kaya","year":"2007","unstructured":"Kaya F, Belin S, Bourgeois P, Micaleff J, Blin O, Font\u00e9s M: Ascorbic acid inhibits PMP22 expression by reducing cAMP levels. \n                           Neuromuscul Disord 2007, 17:248\u2013253.","journal-title":"Neuromuscul Disord"},{"key":"199_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s11940-011-0115-z","volume":"13","author":"A Schenone","year":"2011","unstructured":"Schenone A, Nobbio L, Monti Bragadin M, Ursino G, Grandis M: Inherited neuropathies. \n                           Curr Treat Options Neurol 2011, 13:160\u201379.","journal-title":"Curr Treat Options Neurol"},{"key":"199_CR12","doi-asserted-by":"publisher","first-page":"17180","DOI":"10.1523\/JNEUROSCI.3457-11.2011","volume":"31","author":"B Gess","year":"2011","unstructured":"Gess B, R\u00f6hr D, Fledrich R, Sereda MW, Kleffner I, Humberg A, Nowitzki J, Strecker J-K, Halfter H, Young P: Sodium-dependent vitamin C transporter 2 deficiency causes hypomyelination and extracellular matrix defects in the peripheral nervous system. \n                           J Neurosci 2011, 31:17180\u201392.","journal-title":"J Neurosci"},{"key":"199_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1741-7015-7-70","volume":"7","author":"C Verhamme","year":"2009","unstructured":"Verhamme C, de Haan R, Vermeulen M, Baas F, de Visser M, van Schaik I: Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial. \n                           BMC Med 2009, 7:70.","journal-title":"BMC Med"},{"key":"199_CR14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1474-4422(09)70108-5","volume":"8","author":"J Burns","year":"2009","unstructured":"Burns J, Ouvrier R, Yiu E, Joseph P, Kornberg A, Fahey M, Ryan M: Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial. \n                           Lancet Neurol 2009, 8:537\u2013544.","journal-title":"Lancet Neurol"},{"key":"199_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1600-0404.2008.01134.x","volume":"120","author":"C Toth","year":"2009","unstructured":"Toth C: Poor tolerability of high dose ascorbic acid in a population of genetically confirmed adult Charcot-Marie-Tooth 1A patients. \n                           Acta Neurol Scand 2009, 120:134\u2013138.","journal-title":"Acta Neurol Scand"},{"key":"199_CR16","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S1474-4422(09)70260-1","volume":"8","author":"J Micallef","year":"2009","unstructured":"Micallef J, Attarian S, Dubourg O, Gonnaud P-M, Hogrel J-Y, Stojkovic T, Bernard R, Jouve E, Pitel S, Vacherot F, Remec J-F, Jomir L, Azabou E, Al-Moussawi M, Lefebvre M-N, Attolini L, Yaici S, Tanesse D, Fontes M, Pouget J, Blin O: Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial. \n                           Lancet Neurol 2009, 8:1103\u20131110.","journal-title":"Lancet Neurol"},{"key":"199_CR17","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S1474-4422(11)70025-4","volume":"10","author":"D Pareyson","year":"2011","unstructured":"Pareyson D, Reilly MM, Schenone A, Fabrizi GM, Cavallaro T, Santoro L, Vita G, Quattrone A, Padua L, Gemignani F, Visioli F, Laur\u00e0 M, Radice D, Calabrese D, Hughes RAC, Solari A: Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. \n                           Lancet Neurol 2011, 10:320\u2013328.","journal-title":"Lancet Neurol"},{"key":"199_CR18","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1001\/jamaneurol.2013.3178","volume":"70","author":"RA Lewis","year":"2013","unstructured":"Lewis RA, McDermott MP, Herrmann DN, Hoke A, Clawson LL, Siskind C, Feely SME, Miller LJ, Barohn RJ, Smith P, Luebbe E, Wu X, Shy ME: High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial. \n                           JAMA Neurol 2013, 70:981\u2013987.","journal-title":"JAMA Neurol"},{"key":"199_CR19","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/nm1011-1166","volume":"17","author":"C Ainsworth","year":"2011","unstructured":"Ainsworth C: Networking for new drugs. \n                           Nat Med 2011, 17:1166\u20131168.","journal-title":"Nat Med"},{"key":"199_CR20","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0896-6273(00)80128-2","volume":"16","author":"M Sereda","year":"1996","unstructured":"Sereda M, Griffiths I, P\u00fchlhofer A, Stewart H, Rossner MJ, Zimmerman F, Magyar JP, Schneider A, Hund E, Meinck HM, Suter U, Nave KA: A transgenic rat model of Charcot-Marie-Tooth disease. \n                           Neuron 1996, 16:1049\u20131060.","journal-title":"Neuron"},{"key":"199_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1385\/JMN:28:1:89","volume":"28","author":"V Magnaghi","year":"2006","unstructured":"Magnaghi V, Ballabio M, Consoli A, Lambert JJ, Roglio I, Melcangi RC: GABA receptor-mediated effects in the peripheral nervous system. \n                           J Mol Neurosci 2006, 28:89\u2013102.","journal-title":"J Mol Neurosci"},{"key":"199_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.coph.2008.12.009","volume":"9","author":"C Stein","year":"2009","unstructured":"Stein C, Lang LJ: Peripheral mechanisms of opioid analgesia. \n                           Curr Opin Pharmacol 2009, 9:3\u20138.","journal-title":"Curr Opin Pharmacol"},{"key":"199_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nbt.2786","volume":"32","author":"M Hay","year":"2014","unstructured":"Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J: Clinical development success rates for investigational drugs. \n                           Nat Biotechnol 2014, 32:40\u201351.","journal-title":"Nat Biotechnol"},{"key":"199_CR24","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N: Dose translation from animal to human studies revisited. \n                           FASEB J 2008, 22:659\u2013661.","journal-title":"FASEB J"},{"key":"199_CR25","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1212\/01.WNL.0000156517.00615.A3","volume":"64","author":"ME Shy","year":"2005","unstructured":"Shy ME, Blake J, Krajewski K, Fuerst DR, Laura M, Hahn AF, Li J, Lewis RA, Reilly M: Reliability and validity of the CMT neuropathy score as a measure of disability. \n                           Neurology 2005, 64:1209\u20131214.","journal-title":"Neurology"},{"issue":"16","key":"199_CR26","first-page":"396","volume":"2006","author":"MM Reilly","year":"2005","unstructured":"Reilly MM, de Jonghe P, Pareyson D: 136th ENMC International Workshop: Charcot-Marie-Tooth disease type 1A (CMT1A)8-10 April 2005, Naarden, The Netherlands. \n                           Neuromuscul Disord 2005, 2006(16):396\u2013402.","journal-title":"Neuromuscul Disord"},{"key":"199_CR27","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.nmd.2010.08.001","volume":"20","author":"MM Reilly","year":"2010","unstructured":"Reilly MM, Shy ME, Muntoni F, Pareyson D: 168th ENMC International Workshop: outcome measures and clinical trials in Charcot-Marie-Tooth disease (CMT). \n                           Neuromuscul Disord 2010, 20:839\u2013846.","journal-title":"Neuromuscul Disord"},{"key":"199_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/mus.23614","volume":"47","author":"K Komyathy","year":"2013","unstructured":"Komyathy K, Neal S, Feely S, Miller LJ, Lewis RA, Trigge G, Siskind CE, Shy ME, Ramchandren S: Anterior tibialis CMAP amplitude correlations with impairment in CMT1A. \n                           Muscle Nerve 2013, 47:493\u2013496.","journal-title":"Muscle Nerve"},{"key":"199_CR29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1529-8027.2011.00350.x","volume":"16","author":"SM Murphy","year":"2011","unstructured":"Murphy SM, Herrmann DN, McDermott MP, Scherer SS, Shy ME, Reilly MM, Pareyson D: Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease. \n                           J Peripher Nerv Syst 2011, 16:191\u2013198.","journal-title":"J Peripher Nerv Syst"},{"key":"199_CR30","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1136\/jnnp.2005.081547","volume":"77","author":"RC Graham","year":"2006","unstructured":"Graham RC, Hughes RAC: A modified peripheral neuropathy scale: the overall neuropathy limitations scale. \n                           J Neurol Neurosurg Psychiatry 2006, 77:973\u2013976.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"199_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.nmd.2007.09.006","volume":"18","author":"A Solari","year":"2008","unstructured":"Solari A, Laur\u00e0 M, Salsano E, Radice D, Pareyson D: Reliability of clinical outcome measures in Charcot-Marie-Tooth disease. \n                           Neuromuscul Disord 2008, 18:19\u201326.","journal-title":"Neuromuscul Disord"},{"key":"199_CR32","first-page":"919","volume":"132","author":"GH Guyatt","year":"1985","unstructured":"Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, Berman LB: The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. \n                           Can Med Assoc J 1985, 132:919\u2013923.","journal-title":"Can Med Assoc J"},{"key":"199_CR33","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.apmr.2007.07.011","volume":"88","author":"J-Y Hogrel","year":"2007","unstructured":"Hogrel J-Y, Payan CA, Ollivier G, Tanant V, Attarian S, Couillandre A, Dupeyron A, Lacomblez L, Doppler V, Meininger V, Tranchant C, Pouget J, Desnuelle C: Development of a French isometric strength normative database for adults using quantitative muscle testing. \n                           Arch Phys Med Rehabil 2007, 88:1289\u20131297.","journal-title":"Arch Phys Med Rehabil"},{"key":"199_CR34","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1002\/sim.4780131703","volume":"13","author":"S Senn","year":"1994","unstructured":"Senn S: Testing for baseline balance in clinical trials. \n                           Stat Med 1994, 13:1715\u20131726.","journal-title":"Stat Med"},{"key":"199_CR35","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2307\/2531158","volume":"40","author":"P O\u2019Brien","year":"1984","unstructured":"O\u2019Brien P: Procedures for comparing samples with multiple endpoints. \n                           Biometrics 1984, 40:1079\u20131087.","journal-title":"Biometrics"},{"key":"199_CR36","first-page":"76","volume":"47","author":"BR Logan","year":"2006","unstructured":"Logan BR, Tamhane AC: On O\u2019 Brien\u2019 s OLS and GLS tests for multiple endpoints. \n                           Lect Notes-Monograph Ser 2006, 47:76\u201388.","journal-title":"Lect Notes-Monograph Ser"},{"key":"199_CR37","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1080\/01621459.1989.10478843","volume":"84","author":"SJ Ruberg","year":"1989","unstructured":"Ruberg SJ: Contrasts for identifying the minimum effective dose. \n                           J Am Stat Assoc 1989, 84:816\u2013822.","journal-title":"J Am Stat Assoc"},{"key":"199_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2307\/2533141","volume":"52","author":"AC Tamhane","year":"1996","unstructured":"Tamhane AC, Hochberg Y, Dunnett CW: Multiple test procedures for dose finding. \n                           Biometrics 1996, 52:21\u201337.","journal-title":"Biometrics"},{"key":"199_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/10543409108835010","volume":"1","author":"KE Peace","year":"1991","unstructured":"Peace KE: One-sided or two-sided p values: which most appropriately address the question of drug efficacy? \n                           J Biopharm Stat 1991, 1:133\u2013138.","journal-title":"J Biopharm Stat"},{"key":"199_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/10543409108835012","volume":"1","author":"LD Fisher","year":"1991","unstructured":"Fisher LD: The use of one-sided tests in drug trials: an FDA advisory committee member\u2019s perspective. \n                           J Biopharm Stat 1991, 1:151\u2013156.","journal-title":"J Biopharm Stat"},{"key":"199_CR41","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","volume":"280","author":"J Zhang","year":"1998","unstructured":"Zhang J, Yu KF: What\u2019s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. \n                           JAMA 1998, 280:1690\u20131691.","journal-title":"JAMA"},{"key":"199_CR42","series-title":"RTI Press Publication No. MR-0009-0903","doi-asserted-by":"publisher","DOI":"10.3768\/rtipress.2009.mr.0009.0903","volume-title":"A Mixed Model Approach for Intent-to-Treat Analysis in Longitudinal Clinical Trials with Missing Values","author":"H Chakraborty","year":"2009","unstructured":"Chakraborty H, Gu H: A Mixed Model Approach for Intent-to-Treat Analysis in Longitudinal Clinical Trials with Missing Values, RTI Press Publication No. MR-0009-0903. Research Triangle Park, NC: RTI International; 2009."},{"issue":"6","key":"199_CR43","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1212\/01.wnl.0000181027.21574.df","volume":"65","author":"ME Shy","year":"2005","unstructured":"Shy ME, Rose MR: Charcot-Marie-Tooth disease impairs quality of life: why? And how do we improve it? \n                           Neurology 2005, 65(6):790\u2013791.","journal-title":"Neurology"},{"key":"199_CR44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10072-008-0928-z","volume":"29","author":"L Padua","year":"2008","unstructured":"Padua L, Aprile I, Cavallaro T, Commodari I, Pareyson D, Quattrone A, Rizzuto N, Vita G, Tonali P, Schenone A: Relationship between clinical examination, quality of life, disability and depression in CMT patients: Italian multicenter study. \n                           Neurol Sci 2008, 29:157\u2013162.","journal-title":"Neurol Sci"},{"key":"199_CR45","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nrn3475","volume":"14","author":"KS Button","year":"2013","unstructured":"Button KS, Ioannidis JPA, Mokrysz C, Nosek BA, Flint J, Robinson ESJ, Munaf\u00f2 MR: Power failure: why small sample size undermines the reliability of neuroscience. \n                           Nat Rev Neurosci 2013, 14:365\u2013376.","journal-title":"Nat Rev Neurosci"},{"key":"199_CR46","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1212\/01.wnl.0000297553.36441.ce","volume":"70","author":"ME Shy","year":"2008","unstructured":"Shy ME, Chen L, Swan ER, Taube R, Krajewski KM, Herrmann D, Lewis RA, McDermott MP: Neuropathy progression in Charcot-Marie-Tooth disease type 1A. \n                           Neurology 2008, 70:378\u201383.","journal-title":"Neurology"},{"key":"199_CR47","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1212\/WNL.39.10.1302","volume":"39","author":"PJ Dyck","year":"1989","unstructured":"Dyck PJ, Karnes JL, Lambert EH: Longitudinal study of neuropathic deficits and nerve conduction abnormalities in hereditary motor and sensory neuropathy type 1. \n                           Neurology 1989, 39:1302\u20131302.","journal-title":"Neurology"},{"key":"199_CR48","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00415-004-0578-x","volume":"251","author":"C Verhamme","year":"2004","unstructured":"Verhamme C, van Schaik IN, Koelman JHTM, de Haan RJ, Vermeulen M, de Visser M: Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia. \n                           J Neurol 2004, 251:1491\u20137.","journal-title":"J Neurol"},{"issue":"Pt 12","key":"199_CR49","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1093\/brain\/awp251","volume":"132","author":"C Verhamme","year":"2009","unstructured":"Verhamme C, van Schaik IN, Koelman JHTM, de Haan RJ, de Visser M: The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study. \n                           Brain 2009, 132(Pt 12):3252\u201362.","journal-title":"Brain"},{"issue":"3","key":"199_CR50","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/brain\/120.3.465","volume":"120","author":"PK Thomas","year":"1997","unstructured":"Thomas PK, Marques W, Davis MB, Sweeney MG, King RHM, Bradley JL, Muddle JR, Tyson J, Malcolm S, Harding AE, Street RH: The phenotypic manifestations of chromosome 17p11.2 duplication. \n                           Brain 1997, 120(3):465\u2013478.","journal-title":"Brain"}],"updated-by":[{"DOI":"10.1186\/s13023-016-0463-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,7,7]],"date-time":"2016-07-07T00:00:00Z","timestamp":1467849600000}}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0199-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-014-0199-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0199-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0199-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:12:38Z","timestamp":1630552358000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-014-0199-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["199"],"URL":"https:\/\/doi.org\/10.1186\/s13023-014-0199-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"9 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"199"}}